Example: Heart Attack

Search clinical trials for: Trabedersen

Total 3 results

NCT00844064

Completed

Safety and Tolerability of AP 12009, Administered I.V. in Patients With Advanced Tumors Known to Overproduce TGF-beta-2

Conditions: Pancreatic Neoplasms; Melanoma; Colorectal Neoplasms
NCT00761280

Terminated

Efficacy and Safety of AP 12009 in Patients With Recurrent or Refractory Anaplastic Astrocytoma or Secondary Glioblastoma

Conditions: Anaplastic Astrocytoma; Glioblastoma
NCT00431561

Completed

Phase IIb Clinical Trial With TGF-β2 Antisense Compound AP 12009 for Recurrent or Refractory High-grade Glioma

Conditions: Glioblastoma; Anaplastic Astrocytoma